ArticleExpert review of anti-infective therapy2012
Trichomonas vaginalis: treatment questions and challenges.
Article in Expert review of anti-infective therapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Antimicrobial Activity of D-Form Synthetic Peptides Against Metronidazole-Resistant and SusceptibleInternational journal of molecular sciences · 2026Article
- Introduction of protein vaccine candidate based on AP65, AP33, and α-actinin proteins against Trichomonas vaginalis parasite: an immunoinformatics design.Parasites & vectors · 2024Article
- Direct Measurement of Nucleoside Ribohydrolase Enzyme Activities inAnalytical chemistry · 2023Article
- Association between red blood cell folate and Trichomonas vaginalis infection among women.BMC infectious diseases · 2023Article
- Structure-Guided Insight into the Specificity and Mechanism of a Parasitic Nucleoside Hydrolase.Biochemistry · 2022Article
- Different Drugs, Same End: Ultrastructural Hallmarks of Autophagy in Pathogenic Protozoa.Frontiers in microbiology · 2022Review
- Deazapurine Nucleoside Analogues for the Treatment ofACS infectious diseases · 2021Article
- A review onSouthern African journal of infectious diseases · 2021Review
- Discovery of Ligand-Efficient Scaffolds for the Design of NovelACS omega · 2019Article
- Alternative and complementary therapies for vulvovaginal candidiasis.Folia microbiologica · 2019Review
- Druggability of the guanosine/adenosine/cytidine nucleoside hydrolase from Trichomonas vaginalis.Chemical biology & drug design · 2018Article
- Evaluation of the effect of miltefosine on Trichomonas vaginalis.Parasitology research · 2014Article
- Hydrogenosome metabolism is the key target for antiparasitic activity of resveratrol against Trichomonas vaginalis.Antimicrobial agents and chemotherapy · 2013Article
- Getting trichy: tools and approaches to interrogating Trichomonas vaginalis in a post-genome world.Trends in parasitology · 2013Review
- Endobiont viruses sensed by the human host - beyond conventional antiparasitic therapy.PloS one · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.